Mayne waits for FDA nod as losses rise
SYDNEY: Specialty pharmaceutical company Mayne Pharma Group hopes to get the nod from ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
FEATURED
Las Vegas Sands applauds Singapore results and eyes Macau rebound
Genting Malaysia ‘virtually assured’ of winning downstate NY casino licence
Pagcor boss hails importance of casino resorts for tourism rebound
Evolution eyes end-of-year Gambling Commission review update
Satellite tech fuels illegal gambling ops in Asia